These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1143 related articles for article (PubMed ID: 15327791)

  • 1. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
    Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
    Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of the effect of a naturally occurring mutation in glycoprotein L on Marek's disease virus pathogenesis.
    Santin ER; Shamblin CE; Prigge JT; Arumugaswami V; Dienglewicz RL; Parcells MS
    Avian Dis; 2006 Mar; 50(1):96-103. PubMed ID: 16617990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A deletion in the glycoprotein L (gL) gene of U.S. Marek's disease virus (MDV) field strains is insufficient to confer increased pathogenicity to the bacterial artificial chromosome (BAC)-based strain, RB-1B.
    Shaikh SA; Katneni UK; Dong H; Gaddamanugu S; Tavlarides-Hontz P; Jarosinski KW; Osterrieder N; Parcells MS
    Avian Dis; 2013 Jun; 57(2 Suppl):509-18. PubMed ID: 23901769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of oncogenic genes revealed unique evolutionary features of field Marek's disease virus prevalent in recent years in China.
    Tian M; Zhao Y; Lin Y; Zou N; Liu C; Liu P; Cao S; Wen X; Huang Y
    Virol J; 2011 Mar; 8():121. PubMed ID: 21406076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function.
    Reddy SM; Lupiani B; Gimeno IM; Silva RF; Lee LF; Witter RL
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7054-9. PubMed ID: 11997455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization and phylogenetic analysis of a virulent Marek's disease virus field strain in broiler chickens in Japan.
    Abd-Ellatieff HA; Abou Rawash AA; Ellakany HF; Goda WM; Suzuki T; Yanai T
    Avian Pathol; 2018 Feb; 47(1):47-57. PubMed ID: 28762757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of a recombinant Marek's disease virus in vivo through expression of the Marek's EcoRI-Q (Meq)-encoded oncoprotein: characterization of an rMd5-based mutant expressing the Meq of strain RB-1B.
    Kumar P; Dong H; Lenihan D; Gaddamanugu S; Katneni U; Shaikh S; Tavlarides-Hontz P; Reddy SM; Peters W; Parcells MS
    Avian Dis; 2012 Jun; 56(2):328-40. PubMed ID: 22856190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.
    Ajithdoss DK; Reddy SM; Suchodolski PF; Lee LF; Kung HJ; Lupiani B
    Virus Res; 2009 Jun; 142(1-2):57-67. PubMed ID: 19189855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and characterization of Marek's disease viruses having green fluorescent protein expression tied directly or indirectly to phosphoprotein 38 expression.
    Prigge JT; Majerciak V; Hunt HD; Dienglewicz RL; Parcells MS
    Avian Dis; 2004 Sep; 48(3):471-87. PubMed ID: 15529969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between rate of viral genome replication and virulence of Marek's disease herpesvirus strains.
    Yunis R; Jarosinski KW; Schat KA
    Virology; 2004 Oct; 328(1):142-50. PubMed ID: 15380365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased virulence of Marek's disease virus field isolates.
    Witter RL
    Avian Dis; 1997; 41(1):149-63. PubMed ID: 9087332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host responses in the bursa of Fabricius of chickens infected with virulent Marek's disease virus.
    Abdul-Careem MF; Hunter BD; Lee LF; Fairbrother JH; Haghighi HR; Read L; Parvizi P; Heidari M; Sharif S
    Virology; 2008 Sep; 379(2):256-65. PubMed ID: 18675437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased virulence of Marek's disease virus type 1 vaccine strain CV1988 after adaptation to qt35 cells.
    Majerciak V; Valkova A; Szabová D; Geerligs H; Zelník V
    Acta Virol; 2001 Apr; 45(2):101-8. PubMed ID: 11719980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A MEQ-deleted Marek's disease virus cloned as a bacterial artificial chromosome is a highly efficacious vaccine.
    Silva RF; Dunn JR; Cheng HH; Niikura M
    Avian Dis; 2010 Jun; 54(2):862-9. PubMed ID: 20608531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence analysis of meq oncogene among Polish strains of Marek's disease.
    Woźniakowski G; Samorek-Salamonowicz E; Kozdruń W
    Pol J Vet Sci; 2010; 13(2):263-7. PubMed ID: 20731180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Marek's disease virus in different chicken populations in Iraq and indicative virulence based on sequence variation in the ecoRI-q (meq) gene.
    Wajid SJ; Katz ME; Renz KG; Walkden-Brown SW
    Avian Dis; 2013 Jun; 57(2 Suppl):562-8. PubMed ID: 23901776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marek's disease virus: lytic replication, oncogenesis and control.
    Jarosinski KW; Tischer BK; Trapp S; Osterrieder N
    Expert Rev Vaccines; 2006 Dec; 5(6):761-72. PubMed ID: 17184215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
    Buscaglia C; Nervi P; Risso M
    Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marek's disease: an update on oncogenic mechanisms and control.
    Venugopal K
    Res Vet Sci; 2000 Aug; 69(1):17-23. PubMed ID: 10924389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins.
    Omar AR; Schat KA
    Virology; 1996 Aug; 222(1):87-99. PubMed ID: 8806490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.